MDM2 and breast cancer: The importance of NFAT1 and NFAT1-MDM2 pathway in JapA's anti-breast cancer activity was further demonstrated using Tet-on inducible NFAT1 overexpression (OE) and siRNA NFAT1 knockdown (KD) MCF-7 cells.